A National Research Priority Program of the Logo DFG Deutsche Forschungsgesellschaft


Andreas S, Chenot JF, Diebold R, Peachey S, Mann K (2013) Effectiveness of varenicline as an aid to smoking cessation in primary care: an observational study. Eur Addict Res. 19(1):47-54.

Becker B, Klein EM, Striepens N, Mihov Y, Schlaepfer TE, Reul J, Goossens L, Schruers K, Kendrick KM, Hurlemann R (2013) Nicotinic acetylchloine receptors contribute to learning-induced metaplasticity in the hippocampus. J Cogn Neurosci, 25(7):986-9.

Bernardi R, Spanagel R (2013) The Clock ∆19 mutation in mice fails to alter the primary and secondary reinforcing properties of nicotine. Drug Alcohol Depend. 133(2):733-9.

Drusch K, Lowe A, Fisahn K, Brinkmeyer j, Musso F, Mobascher A, Warbrick T, Shah J, Ohmann C, Winterer G, Wölwer W (2013) Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls. Eur Arch Psychiatry Clin Neurosci. 263(6):519-27.

Eggert M, Aichinger E, Pfaffl MW, Steinlein OK, Pfob M (2013) Nicotinic acetylcholine receptor subunits α4 and α5 associated with smoking bahaviour and lung cancer are regulated by upstream open reading frames. PLoS One. 8(7):e66157.

Effertz T, Mann K (2013) The burden and cost of disorders of the brain in Europe with the inclusion of harmful alcohol use and nicotine addiction. Eur Neuropsychopharmacol. 23(7):742-8.

Grundey J, Freznosa S, Klinker F, Lang N, Paulus W, Nitsche MA (2013) Cortical excitability in smoking and not smoking individuals with and without nicotine. Psychopharmacology 229(4):653-64.

Kanwar J, Okusaga O, Giegling I, Konte B, Vaswani D, Sleemi A, Vaswani R, Hartmann AM, Friedl M, Hong LE, Reeves G, Stephens S, Dixon L, Rujescu D, Postolache TT (2013) In patients with schizophrenia, non-fatal suicidal self-directed violence is positively associated with present but not past smoking. Schizophr Res. 149(1-3):194-5.

Kroemer NB, Guevara A, Vollstädt-Klein S, Smolka MN (2013) Nicotine alters food-cue reactivity via networks extending from the hypothalamus. Neuropsychopharmacology. 38(11):2307-14.

Müller KU, Mennigen E, Ripke S, Banaschewski T, Barker GJ, Büchel C, Conrod P, Fauth-Bühler M, Flor H, Garavan H, Heinz A, Lawrence C, Loth E, Mann K, Martinot JL, Pausova Z, Rietschel M, Ströhle A, Struve M, Walaszek B, Schumann G, Paus T, Smolka MN; IMAGEN Consortium (2013) Altered reward processing in adolescents with prenatal exposure to maternal cigarette smoking. JAMA Psychiatry. 70(8):847-56.  

Mutschler J, Abbruzzese E, von der Goltz C, Dinter C, Mobascher A, Thiele H, Diaz-Lacava A, Dahmen N, Gallinat J, Majic T, Petrovsky N, Thuerauf N, Kornhuber J, Gründer G, Rademacher L, Brinkmeyer J, Wienker T, Wagner M, Winterer G, Kiefer F (2013) Lack of association of a functional catechol-O-methyltransferase gene polymorphism with risk of tobacco smoking: results from a multicenter case-control study. Nicotine Tob Res, 15(7):1322-1.

Nees F, Witt SH, Lourdusamy A, Vollstädt-Klein S, Steiner S, Poustka L, Banaschweski T, Barker GJ, Blüchel C, Conrod PJ, Frank J, Gallinat J, Garavan H, Heinz A, Ittermann B, Loth E, Mann K, Artiges E, Paus T, Pausova Z, Smolka MN, Schumann G, Rietschel M, Flor H; IMAGEN consortium (2013) Genetic risk for nicotine dependence in the cholinergic system and activation of the brain reward system in healthy adolescents. Neuropsychopharmacology. 38(11):2081-9. 

Petrovsky N, Ettinger U, Kessler H, Mössner R, Wolfsgruber S, Dahmen N, Maier W, Wagner M, Quednow BB (2013) The effect of nicotine on sensorimotor gating is modulated by a CHRNA3 polymorphism. Psychopharmacology. 229(1):31-40.

Petrovsky N, Ettinger U, Quednow BB, Landsberg MW, Drees J, Lennertz L, Frommann I, Heilmann K, Sträter B, Kessler H, Dahmen N, Mössner R, Maier W, Wagner M (2013) Nicotine enhances antisaccade performance in schizophrenia patients and healty controls. Int J Neuropsychopharmacol, 16(7):1473-81.

Richter N, Warbrick T, Mobascher A, Brinkmeyer J, Musso F, Stoecker T, Shah NJ, Fink GR, Winterer G (2013) Epoch versus impulse models in the analysis of parametric fMRI studies. Clin Neurophysiol. 124(5):956-66.

Tozzi F, Teumer A, Munafò M, Rawal R, Kazeem G, Gerbaulet M, McArdle W, Chilcoat H, Döring A, Dahmen N, Mooser V, Nauck M, Ring SM, Rubio JP, Vollenweider P, Waeber G, John U, Völzke H, Homuth G, Freyberger HJ, Völker U, Davey-Smith G, Gieger C, Preising M, Grabe HJ (2013) A genomwide association study of smoking relapse in four European population-based samples. Psychiatr Genet. 23(4):143-52.

Wagner M, Schulze-Rauschenbach S, Petrovsky N, Brinkmeyer J, von der Goltz C, Gründer G, Spreckelmeyer KN, Wienker T, Diaz-Lacava A, Mobascher A, Dahmen N, Clepce M, Thuerauf N, Kiefer F, de Millas JW, Gallinat J, Winterer G (2013) Neurocognitive impairments in non-deprived smokers - results from a population -based multi-center study on smoking-related bahavior. Addict. Biol. 18(4):752-61.

Wiers CE, Kühn S, Javadi AH, Korucuoglu O, Wiers RW, Walter H, Gallinat J, Bermpohl F (2013) Automatic approach bias towards smoking cues is present in smokers but not in ex-smokers. Psychopharmacology. 229(1):187-97.

Winterer G, Gallinat J, Brinkmeyer J, Musso F, Kornhuber J, Thuerauf N, Rujescu D. Favis R, Sun Y, Franc MA, Ouwerkerk-Mahadevan S, Janssens L, Timmers M, Streffer JR (2013) Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schiziophrenia: a proof-of-mechanism study. Neuropharmacology. 64:197-204.